2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $3.8B | $3.9B | $3.8B | $4.2B | $4.7B |
Cost of Revenue | $1.6B | $1.8B | $1.6B | $1.7B | $1.9B |
Gross Profit | $2.2B | $2.2B | $2.2B | $2.5B | $2.8B |
Gross Profit % | 57% | 55% | 58% | 59% | 60% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $709M | $1.3B | $820M | $944M | $1.1B |
Dep. & Amort. | $604M | $636M | $649M | $704M | $788M |
Def. Tax | $207M | $230M | $80M | $208M | $0 |
Stock Comp. | $21M | $17M | $28M | $25M | $0 |
Chg. in WC | -$55M | $126M | -$355M | $27M | -$12M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $547M | $116M | $85M | $330M | $96M |
ST Investments | $11M | $17M | $67M | $62M | $0 |
Cash & ST Inv. | $547M | $116M | $85M | $330M | $96M |
Receivables | $527M | $568M | $609M | $727M | $756M |
Inventory | $47M | $57M | $98M | $112M | $103M |
AWK reported Q1 2025 earnings of $1.05 per share, an 11% increase from $0.95 last year, and affirmed full-year 2025 EPS guidance, targeting 8% EPS growth over weather-normalized 2024.
The company’s Board approved an 8.2% increase in the quarterly dividend to $0.8325 per share, and AWK reaffirmed its long-term targets for both earnings and dividend growth at 7%-9%, driven by 8%-9% rate base growth.
Regulatory progress included constructive rate case settlements in Missouri (awaiting final order for a $63M annualized revenue increase) and Virginia (approved $15M annualized increase, 9.7% ROE, and higher equity ratio), with additional active cases in Iowa, Hawaii, and California.
AWK invested $518M in capital in Q1, on track for ~$3.3B in 2025, with a focus on infrastructure upgrades, PFAS/lead remediation, and acquisitions; the company maintains a robust acquisition pipeline with 37,000 customer connections under agreement.
Credit ratings were affirmed by S&P (A) and Moody’s (Baa1), with a stable outlook; recent $800M debt issuance at 5.25% coupon supports financing needs, and total debt to capital ratio remains within target at 58%.